ATTGENO AB
Developing targeted nitric oxide delivery drugs for critical care applications.
Oversigt
- 2
- Medarbejdere
- 0 SEK
- Omsætning
- 2005
- Grundlagt
Beskrivelse
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556692775101
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Cereno Scientific AB
10–19 medarbejderePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
3 medarbejdereDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 medarbejdereDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
3 medarbejdereDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 medarbejdereDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Udforsk mere
Spørgsmål om ATTGENO AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo